首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1593490

反應器市場規模、佔有率和成長分析（按材料、使用階段、控制方法和地區）：產業預測（2024-2031）

Bioreactors Market Size, Share, Growth Analysis, By Materials (Glass, Stainless Steel), By Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), By Control Type (Manual, and Automated) By Region - Industry Forecast 2024-2031

出版日期: 2024年11月08日 | 出版商:

SkyQuest | 英文 177 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球反應器市場規模約為135萬美元，從2023年的146萬美元成長到2031年的268萬美元，並在預測期內（2024-2031年）成長790萬美元。為%。

由於製藥和生物製藥領域的使用增加，全球反應器市場正在經歷強勁成長。反應器在推進研究和開發過程中發揮重要作用，特別是在受控條件下培養用於治療慢性疾病的生物體。對單株抗體的需求不斷成長以及政府對疫苗生產的資助進一步推動了市場擴張。此外，一次性反應器的日益普及對產生收入做出了重大貢獻，反映出該行業正在轉向經濟高效且靈活的解決方案。技術進步增強了反應器的能力，並實現了可提高效率和結果的創新功能。不斷擴大的製藥和生物技術行業以及私營組織不斷增加的投資，使得從藥物開發到工業生產等廣泛應用對反應器的依賴日益增加。透過這種方式，反應器被定位為解決世界各地醫療問題不可或缺的工具，並正在推動市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 波灣合作理事會(GCC) 國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（%，2023年）

主要企業簡介

賽多利斯股份公司（德國）
賽默飛世爾科技公司（美國）
通用電氣（美國）
艾本德股份公司（德國）
默克公司（德國）
頗爾公司（美國）
ZETA（印度）
PRaj Hippurity Systems Limited（印度）
生物工程股份公司（瑞士）
Infors AG（瑞士）
Solaris Biotechnology Srl.（唐納森公司）（義大利）
Bbi生物技術（德國）
上海百倫生物科技有限公司 (中國)
PBS Biotech Inc.（美國）
CerCell A/S（丹麥）
GEA 集團股份公司（德國）
M+W 集團（德國）
德希尼佈公司（法國）
雅各布斯工程集團公司（美國）

簡介目錄

Product Code: SQMIG35H2293

Global Bioreactors Market size was valued at around USD 1.35 million in 2022 and is expected to rise from USD 1.46 million in 2023 to reach a value of USD 2.68 million by 2031, at a CAGR of 7.9% over the forecast period (2024-2031).

The global bioreactors market is experiencing robust growth, driven by their increasing use in the pharmaceutical and biopharmaceutical sectors. Bioreactors play a critical role in advancing procedures for research and development, particularly in cultivating organisms used to treat chronic illnesses under controlled conditions. The rising demand for monoclonal antibodies and government-backed funding for vaccine production further fuel market expansion. Additionally, the growing adoption of single-use bioreactors significantly contributes to revenue generation, reflecting the industry's shift toward cost-effective and flexible solutions. Technological advancements have enhanced bioreactor capabilities, enabling innovative features that improve efficiency and outcomes. The expanding pharmaceutical and biotechnology industries, coupled with rising investments from private organizations, underscore the growing reliance on bioreactors for diverse applications, from drug development to industrial processes. This convergence of factors positions bioreactors as essential tools in addressing global healthcare challenges while driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioreactors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioreactors Market Segmental Analysis

Global Bioreactors Market is segmented by Materials, Scale, Usage, Application, Control Type, Suppliers, End-Users and region. Based on Materials, the market is segmented into Glass, Stainless Steel, Single-Use, and Others. Based on Scale, the market is segmented into 5L-20L, 20L-200L, 200L-1500L, and Above 1500L. Based on Application, the market is segmented into Antibodies, Vaccines, Cell Therapies, Others. Based on Usage, the market is segmented into Lab-Scale Production, Pilot-Scale Production, Full-Scale Production, and Others. Based on Control Type, the market is segmented into Manual, and Automated (MFCs). Based on Suppliers, the market is segmented into OEMs (Original Equipment Manufacturers), System Integrators, EPCs (Engineering Procurement and Construction). Based on End User, the market is segmented into R&D Institutes, Contract Research Organizations, Biopharmaceutical Manufacturers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Bioreactors Market

The increasing utilization of bioreactors for manufacturing various vaccines, which play a crucial role in mitigating numerous diseases, is significantly driving the growth of the global bioreactors market. The recent outbreak of the COVID-19 pandemic highlighted the critical need for effective vaccine production, leading to a surge in demand for clinical-stage bioreactors. Pharmaceutical companies extensively adopted bioreactors to meet the heightened demand and successfully deliver preventive vaccines to the market. This trend underscores the pivotal role of bioreactors in accelerating vaccine development and production processes, making them indispensable for combating existing and emerging health crises. As a result, the market is witnessing robust growth driven by advancements in bioprocessing technologies and the urgent need for scalable solutions in vaccine manufacturing.

Restraints in the Global Bioreactors Market

The global bioreactors market faces a significant restraint due to the limitations of single-use bioreactors. Despite the availability of various bioreactor types, single-use bioreactors are hindered by their limited capacity and inability to support prolonged operations. These constraints pose substantial challenges, particularly in processes requiring high scalability and extended durations, making them less viable for pharmaceutical and biopharmaceutical companies. Consequently, the adoption of single-use bioreactors has been adversely affected, creating a bottleneck in the market's growth. This limitation highlights the need for advanced bioreactor technologies capable of addressing these challenges while maintaining the benefits of single-use systems, such as cost efficiency and flexibility, to enable broader market expansion.

Market Trends of the Global Bioreactors Market

The global bioreactors market is witnessing significant growth driven by continuous innovations in bioreactor design and processing technologies. Manufacturers are actively developing advanced, cost-efficient bioreactors that enable the large-scale production of various products, enhancing operational efficiency and reducing costs. These technological advancements not only improve bioprocessing capabilities but also offer several advantages, such as higher productivity and streamlined processes, further boosting market demand. The integration of cutting-edge features in bioreactors is contributing to increased adoption across industries, resulting in higher revenue generation and market expansion. This trend underscores the pivotal role of technology in shaping the future of the bioreactors market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Innovation Matrix
Regulatory Analysis
Case Study Analysis
Technology Analysis
Patent Analysis

Bioreactor Market, By Materials

Market Overview
Glass
Stainless Steel
Single-Use
Others

Bioreactor Market, By Scale

Market Overview
5L-20L
20L-200L
200L-1500L
Above 1500L

Bioreactor Market, By Application

Market Overview
Antibodies
Vaccines
Cell Therapies
Others

Bioreactor Market, By Usage

Market Overview
Lab-Scale Production
Pilot-Scale Production
Full-Scale Production
Others

Bioreactor Market, By Control Type

Market Overview
Manual
Automated (MFCs)

Bioreactor Market, By Suppliers

Market Overview
OEMs (Original Equipment Manufacturers)
System Integrators
EPCs (Engineering Procurement and Construction)

Bioreactor Market, By End User

Market Overview
R&D Institutes
Contract Research Organizations
Biopharmaceutical Manufacturers
Others

Bioreactor Market, Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZETA (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRaj Hipurity Systems Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioengineering AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Infors AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solaris Biotechnology Srl. (Donaldson Company) (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bbi Biotech (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Bailun Biotechnology co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PBS Biotech Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CerCell A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GEA Group Aktiengesellschaft (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
M+W Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Technip S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jacobs Engineering Group Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments